Your browser doesn't support javascript.
loading
Follow-up of humoral immune response after HPV vaccination using first-void urine: A longitudinal cohort study.
Téblick, Laura; Pattyn, Jade; Van Keer, Severien; De Smet, Annemie; De Coster, Ilse; Tjalma, Wiebren A A; Rajbhandari, Ira; Panicker, Gitika; Unger, Elizabeth R; Vorsters, Alex.
Affiliation
  • Téblick L; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Pattyn J; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Van Keer S; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • De Smet A; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • De Coster I; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Tjalma WAA; Multidisciplinary Breast Clinic, Gynecological Oncology Unit, Department of Obstetrics and Gynecology. Antwerp University Hospital (UZA) (Belgium), Molecular Imaging, Pathology, Radiotherapy, and Oncology (MIPRO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Rajbhandari I; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Panicker G; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Unger ER; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Vorsters A; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
J Med Virol ; 95(10): e29133, 2023 10.
Article de En | MEDLINE | ID: mdl-37812015
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à papillomavirus / Vaccins contre les papillomavirus Type d'étude: Clinical_trials / Etiology_studies / Observational_studies Limites: Female / Humans Langue: En Journal: J Med Virol Année: 2023 Type de document: Article Pays d'affiliation: Belgique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à papillomavirus / Vaccins contre les papillomavirus Type d'étude: Clinical_trials / Etiology_studies / Observational_studies Limites: Female / Humans Langue: En Journal: J Med Virol Année: 2023 Type de document: Article Pays d'affiliation: Belgique